A Study of KK2269 in Adult Participants With Solid Tumors
Phase 1
71
about 4 years
18+
7 sites in AZ, CA, FL +3
What this study is about
Researchers are testing a new drug called KK2269 to see if it's safe and well-tolerated. The trial will involve adults with advanced or metastatic solid tumors for which no standard therapy is available. It is also investigating the safety of KK2269 when combined with docetaxel in patients who have already received other treatments.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Docetaxel
- 2.Take KK2269
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
docetaxel
infusion
Primary: Number of Adverse Events, Number of Subjects Experiencing Dose-limiting Toxicity
Oncology